TP53 and cancer: Maintaining genome stability by transactivating the DNA damage response (DDR) genes is the critical mediator of TP53-dependent tumor suppression [12, 13]; thus, TP53 deficiency causes the loss of various DDR mechanisms and thereby facilitates genome instability and cancer development [13].